This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nakamura, Y. Articles by Sasano, H. Search for Related Content PubMed PubMed Citation Articles by Nakamura, Y. Articles by Sasano, H.

(American Journal of Pathology. 2006;169:362-371.)
© 2006 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2006.051351

MDM2

A Novel Mineralocorticoid-Responsive Gene Involved in Aldosterone-Induced Human Vascular Structural Remodeling

Yasuhiro Nakamura^*, Saya Suzuki^*, Takashi Suzuki^*, Katsuhiko Ono^*, Ikumi Miura^*, Fumitoshi Satoh, Takuya Moriya^*, Haruo Saito, Shogo Yamada, Sadayoshi Ito and Hironobu Sasano^*

From the Department of Pathology,^* the Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, and the Department of Radiology, Tohoku University Graduate School of Medicine, Sendai; and the Department of Radiology, Sendai Medical Center, Sendai, Japan

Aldosterone has been demonstrated to play an important role in the pathogenesis of various cardiovascular diseases. Vascular structural remodeling, including vascular smooth muscle cell (VSMC) proliferation, has been also reported in small resistance arteries of patients with primary aldosteronism. Therefore, in this study, we examined whether genes involved in the regulation of the cell cycle were induced by aldosterone alone in cultured human VSMCs and in human small resistance arteries. Results of these studies eventually demonstrated that MDM2, one of the genes involved in anti-apoptosis and cell growth, was markedly increased in mineralocorticoid receptor (MR)-positive VSMCs by aldosterone in all microarray, reverse transcriptase-polymerase chain reaction, immunoblotting, and immunofluorescence analyses. In addition, an analysis using small interfering RNA demonstrated that this gene product was involved in cell proliferation of VSMCs induced by aldosterone. Eplerenone, a specific MR antagonist, inhibited this gene induction by aldosterone in VSMCs. MDM2 protein was also more abundant in VSMCs of small resistance arteries in patients with primary aldosteronism compared with a control population. MDM2 is therefore considered one of the mineralocorticoid-responsive genes that regulates cell proliferation of VSMCs induced by MR-mediated aldosterone stimulation, possibly playing an important role in aldosterone-induced vascular structural remodeling.